AQUINNAH PHARMACEUTICALS
Aquinnah Pharmaceuticals is focused on an exciting new area of research and development to modulate neurodegenerative stress granules, believed to be important in the pathology of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
AQUINNAH PHARMACEUTICALS
Industry:
Health Care Hospital Medical Pharmaceutical
Founded:
2006-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.aquinnahpharma.com
Total Employee:
11+
Status:
Active
Contact:
+1 617-863-3678
Total Funding:
19.83 M USD
Technology used in webpage:
U.S. Server Location Pound Sterling
Similar Organizations
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Amalgamated Medical Care Management
Amalgamated Medical Care Management provides care management, wellness, health, disease, and case management services.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Centre Hospitalier Universitaire (CHU) de Québec-Université Laval
Centre Hospitalier Universitaire (CHU) de Québec-Université Laval strives for excellence and offers care and services.
Ophthalmic Consultants of Long Island - OCLI
Ophthalmic Consultants of Long Island is a medical practice company providing diabetic eye care and laser cataract surgery.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Unified Women's Healthcare
Unified Women's Healthcare is a management services company that specializes in administrative and business support services.
Current Advisors List
Current Employees Featured
Founder
Investors List
Alzheimer's Association
Alzheimer's Association investment in Grant - Aquinnah Pharmaceuticals
Tau Consortium
Tau Consortium investment in Grant - Aquinnah Pharmaceuticals
National Institutes of Health
National Institutes of Health investment in Grant - Aquinnah Pharmaceuticals
AbbVie
AbbVie investment in Venture Round - Aquinnah Pharmaceuticals
Pfizer
Pfizer investment in Venture Round - Aquinnah Pharmaceuticals
Takeda
Takeda investment in Venture Round - Aquinnah Pharmaceuticals
National Institutes of Health
National Institutes of Health investment in Grant - Aquinnah Pharmaceuticals
Official Site Inspections
http://www.aquinnahpharma.com
- Host name: cloudproxy10088.sucuri.net
- IP address: 192.124.249.88
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aquinnah Pharmaceuticals"
Aquinnah Pharmaceuticals - Crunchbase Company …
Aquinnah Pharmaceuticals is focused on an exciting new area of research and development to modulate neurodegenerative stress granules, believed to be important in the pathology of amyotrophic lateral sclerosis (ALS), also known …See details»
A bold new approach to neurodegenerative disease
Dr. Ben Wolozin, M.D., Ph.D., CSO and co-founder of Aquinnah Pharmaceuticals, pioneered the groundbreaking connection between stress granules and neurodegenerative diseases — a …See details»
The Team - Aquinnah Pharmaceuticals
After leaving MRL, Joe served as Senior VP of International Discovery Services at WuXi Apptec, a leading global discovery and life sciences services organization in China. Joe has consulted …See details»
Aquinnah Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Last update 01 Nov 2024. Aquinnah Pharmaceuticals, Inc. Holding Company |See details»
Aquinnah Pharmaceuticals - LinkedIn
Aquinnah Pharmaceuticals | 1,676 followers on LinkedIn. Aquinnah Pharmaceuticals is focused on a new area of research and development to modulate neurodegenerative stress granules, believed to be ...See details»
Aquinnah Company Profile 2024: Valuation, Funding
Aquinnah General Information Description. Developer of neurodegenerative stress granules intended for the treatment of critical diseases. The company leverages brain pathology to design innovative therapies to slow the …See details»
Aquinnah Pharmaceuticals - Craft
Aquinnah Pharmaceuticals has 5 employees at their 1 location and $19.83 m in total funding,. See insights on Aquinnah Pharmaceuticals including office locations, competitors, revenue, …See details»
Aquinnah Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
Oct 30, 2023 Aquinnah Pharmaceuticals contact info: Phone number: (617) 863-3678 Website: www.aquinnahpharma.com What does Aquinnah Pharmaceuticals do? Aquinnah …See details»
Aquinnah Pharmaceuticals Company Profile -Sales, Contacts, …
Aquinnah Pharmaceuticals is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 9 years.See details»
Aquinnah Pharmaceuticals Inc. - VentureRadar
Aquinnah Pharmaceuticals Inc. VentureRadar profile. Find out more about Aquinnah Pharmaceuticals Inc., ALS and ALS targeting drugs.See details»
Aquinnah Pharmaceuticals - workinbiotech.com
Aquinnah Pharmaceuticals is developing drugs for neurodegenerative diseases. Recent scientific research has found a connection between stress granules and neurodegenerative diseases …See details»
Exceptional Science — Aquinnah Pharmaceuticals
Aquinnah has been awarded eight peer-reviewed grants, two from the ALS Association, four from the National Institute of Health, one from the Alzheimer’s Association and Rainwater …See details»
Aquinnah Pharmaceuticals Advances Oral Small Molecule
Oct 30, 2023 More information is available at www.aquinnahpharma.com. SOURCE Aquinnah Pharmaceuticals. ... Organization Profile. Aquinnah Pharmaceuticals. Contact Cision. 866-245 …See details»
Aquinnah Pharmaceuticals Receives $750,000 Grant from the …
Jan 17, 2019 /PRNewswire/ -- Aquinnah Pharmaceuticals, leaders in stress granule biology that afflict a wide range of neurodegenerative disorders, announced today that it...See details»
Aquinnah Pharmaceuticals Receives $0.5M In Grants From the ALS …
Jul 17, 2015 /PRNewswire/ -- Aquinnah Pharmaceuticals announced today that it has received two grants totaling $500,000 from the ALS Association to support its research to...See details»
Contact - Aquinnah Pharmaceuticals
Aquinnah pharmaceuticals is located in cambridge at the engine, a biotech innovation hubSee details»
Aquinnah Pharmaceuticals Advances Oral Small Molecule Program …
Oct 30, 2023 New preclinical data presented at CTAD demonstrates exciting potential for a new drug approach for Alzheimer's disease, reducing brain tau pathology by ~70%See details»
News and Announcements - Aquinnah Pharmaceuticals
Cambridge, MA – October 24, 2023 – Aquinnah Pharmaceuticals, leaders in stress granule biology that afflict a wide range of neurodegenerative disorders, today announced that the …See details»
Aquinnah Pharmaceuticals Presents New Therapeutic Approaches …
Apr 27, 2016 Aquinnah Contacts – [email protected]. About The ALS Association. The ALS Association is a national non-profit organization fighting Lou Gehrig’s disease on …See details»